Clinical Trial Information

Randomized Phase III Trial of MFOLFIRINOX +/- NIVOLUMAB VS. FOLFOX +/- NIVOLUMAB for First - Line Treatment of Metastatic HER2-NEGATIVE Gastroesophageal Adenocarcinoma

Protocol Number: A022102
Status: Open
Age Group: Adult
Treatment Type: Treatment
Phase: III
NCT ID: NCT05677490

Scope Information

Scope:: National
Disease Site(s):: Esophagus